Rebecca Baus
Credentials: B.A.
Position title: Molecular, Cell Line Authentication, Spatial and Molecular Profiling, IHC-IF, ISH/FISH
Email: rmbaus@wisc.edu
Biography
Becky brings 24 years of experience to TRIP lab where she specializes in Spatial and Molecular profiling using multiple platforms, DNA/RNA extraction from archived or fresh tissue, Cell Line Authentication by STR Analysis, and custom assays based on client’s needs. In addition to her molecular work, she carries out projects involving IHC-IF and ISH/FISH single and multi-plex staining.
Publications
Albertini,M.R.; Zuleger,C.L.; Ranheim, E.A.; Shiyanbola, O.; Sondel, P.M.; Morris, Z.S.; Eickhoff, J.; Newton, M.; Ong, I.M.; Schwartz, R.W.; Hayim, R.; Kurzman, I.D.; Michelle, T.; Vail, D.M. Administration of intratumoral GD2-directed interleukin-2immunocytokine and local radiation therapy to activate rejection of spontaneous canine melanoma. Melanoma Research 2024 Aug 1;34(4):307-318. PMID: 38768442. https://journals.lww.com/melanomaresearch/abstract/2024/08000/administration_of_intratumoral_gd2_directed.3.aspx
Su S, Ndiaye MA, Guzmán-Pérez G, Baus RM, Huang W, Patankar MS, Ahmad N.Cancers (Basel). Potential tumor suppressor role of Polo-Like Kinase 5 in cancer.2023 Nov 17;15(22):5457. doi: 10.3390/cancers15225457.PMID: 38001717
Lozar, T,; Laklouk, I.; Golfinos, A.E.; Gavrielatou, N., Xu, J.; et al. Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck Squamous Cell Carcinomas and Beyond. Cancers. 2023, Oct, 9. https://doi.org/10.3390/cancers15194905
Roy M, Buehler DG, Zhang R, Schwalbe ML, Baus RM, Salamat MS, Lloyd RV, Rosenbaum JN. Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites. Endocr Pathol. 2019 Mar;30(1):35-42. doi: 10.1007/s12022-018-9559-y.PMID: 30523500
Rush, P. S., Rosenbaum, J. N., Roy, M., Baus, R. M., Bennett, D. D., & Lloyd, R. V. (2017). Insulinoma-associated 1: A novel nuclear marker in Merkel cell carcinoma (cutaneous neuroendocrine carcinoma). Journal of Cutaneous Pathology. doi:10.1111/cup.13079 https://www.ncbi.nlm.nih.gov/pubmed/29148079
Mandal, R., Hardin, H., Baus, R., Rehrauer, W., & Lloyd, R. V. (2017). Analysis of miR-96 and miR-133a Expression in Gastrointestinal Neuroendocrine Neoplasms. Endocrine Pathology, 28(4), 345-350. doi:10.1007/s12022-017-9504-5 https://www.ncbi.nlm.nih.gov/pubmed/29032398
Gertz, R. J., Nikiforov, Y., Rehrauer, W., Mcdaniel, L., & Lloyd, R. V. (2016). Mutation in BRAF and Other Members of the MAPK Pathway in Papillary Thyroid Carcinoma in the Pediatric Population. Archives of Pathology & Laboratory Medicine, 140(2), 134-139. doi:10.5858/arpa.2014-0612-oa https://www.ncbi.nlm.nih.gov/pubmed/26910217
Rosenbaum JN, Guo Z, Baus RM, Werner H, Rehrauer WM, Lloyd RV. INSM1: A Novel Immunohistochemical and Molecular Marker for Neuroendocrine and Neuroepithelial Neoplasms. Am J Clin Pathol. 2015 Oct;144(4):579-91. doi: 10.1309/AJCPGZWXXBSNL4VD.PMID: 26386079.
Czarny MJ, Babcock K, Baus RM, Manoharan H, Pitot HC. Hepatocellular carcinomas of the albumin SV40 T-antigen transgenic rat display fetal-like re-expression of lgf2 and deregulation of H19. Mol Carcinog. 2007 Sep;46(9):747-57. doi: 10.1002/mc.20286.PMID: 17393425